A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2-vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life

Gaspard, U., Taziaux, M., Jost, M., Coelingh Bennink, H. J. T., Utian, W. H., Lobo, R. A., & Foidart, J.-M. (2023). A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2—vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life. Menopause, 30(5), 480–489. https://doi.org/10.1097/gme.0000000000002167
Authors:
Ulysse Gaspard
Mélanie Taziaux
Maud Jost
Herjan J T Coelingh Bennink
Wulf H Utian
Rogerio A Lobo
Jean-Michel Foidart
Affiliated Authors:
Rogerio A Lobo
Author Keywords:
estetrol (e4)
genitourinary syndrome of menopause
health-related quality of life
pain associated with sexual activity
spectrum of menopausal symptoms
vaginal dryness
vulvovaginal atrophy
Publication Type:
Article
Unique ID:
10.1097/gme.0000000000002167
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: